Systematic Reviews
Copyright ©The Author(s) 2025.
World J Clin Pediatr. Jun 9, 2025; 14(2): 104797
Published online Jun 9, 2025. doi: 10.5409/wjcp.v14.i2.104797
Table 3 Specific anti-microbial roles of some human milk oligosaccharides
HMO type
Key pathogens targeted
Mode of action
2'-FLCampylobacter jejuni, EPEC, Norovirus, RSV, RotavirusAnti-adhesive activity, inhibition of pathogen attachment to epithelial cells, by acting as a decoy receptor
3-FLEPEC, Pseudomonas aeruginosa, Salmonella enterica, and Norovirus (pathogens commonly encountered later in infancy)The prebiotic effect promotes beneficial bacteria and blocks pathogen adhesion
DFLEscherichia coli, Campylobacter jejuni, Salmonella enterica, Helicobacter pyloriAnti-adhesive activity preventing pathogen attachment to epithelial cells; supports immune modulation and gut barrier function
LNTEntamoeba histolytica, GB. streptococcus, Vibrio cholera toxinNeutralization of bacterial toxins and prevention of protozoal adhesion
3'-SLEPEC, Helicobacter pylori, Pseudomonas aeruginosa, Vibrio cholera toxin, RSV, RotavirusBlocking bacterial adhesion and neutralizing bacterial toxins
6'-SLEPEC, Helicobacter pylori, Pseudomonas aeruginosa, Influenza virus, RotavirusInhibition of bacterial and viral adherence, especially in respiratory and gastrointestinal infections